120 related articles for article (PubMed ID: 12034058)
1. Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning.
Pantos CI; Malliopoulou VA; Mourouzis IS; Karamanoli EP; Paizis IA; Steimberg N; Varonos DD; Cokkinos DV
Thyroid; 2002 Apr; 12(4):325-9. PubMed ID: 12034058
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart.
Pantos C; Malliopoulou V; Paizis I; Moraitis P; Mourouzis I; Tzeis S; Karamanoli E; Cokkinos DD; Carageorgiou H; Varonos D; Cokkinos DV
Mol Cell Biochem; 2003 Jan; 242(1-2):173-80. PubMed ID: 12619880
[TBL] [Abstract][Full Text] [Related]
3. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
[TBL] [Abstract][Full Text] [Related]
4. Ischemic preconditioning fails to confer additional protection against ischemia-reperfusion injury in the hypothyroid rat heart.
Mourouzis I; Dimopoulos A; Saranteas T; Tsinarakis N; Livadarou E; Spanou D; Kokkinos AD; Xinaris C; Pantos C; Cokkinos DV
Physiol Res; 2009; 58(1):29-38. PubMed ID: 18198989
[TBL] [Abstract][Full Text] [Related]
5. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning.
da Silva R; Grampp T; Pasch T; Schaub MC; Zaugg M
Anesthesiology; 2004 Jan; 100(1):59-69. PubMed ID: 14695725
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
Weinbrenner C; Liu GS; Cohen MV; Downey JM
J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
[TBL] [Abstract][Full Text] [Related]
8. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
9. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
Das S; Tosaki A; Bagchi D; Maulik N; Das DK
J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
[TBL] [Abstract][Full Text] [Related]
12. Different preconditioning stimuli invoke disparate electromechanical and energetic responses to global ischemia in rat hearts.
Rehring TF; Bender PR; Cairns CB; Joo K; Friese RS; Shapiro JI; Cleveland JC; Banerjee A
Can J Physiol Pharmacol; 1997 Apr; 75(4):335-42. PubMed ID: 9196860
[TBL] [Abstract][Full Text] [Related]
13. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
[TBL] [Abstract][Full Text] [Related]
14. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
15. Myocardial protection by ischemic preconditioning and delta-opioid receptor activation in the isolated working rat heart.
Karck M; Tanaka S; Bolling SF; Simon A; Su TP; Oeltgen PR; Haverich A
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):986-92. PubMed ID: 11689805
[TBL] [Abstract][Full Text] [Related]
16. Long-term thyroxine administration increases heat stress protein-70 mRNA expression and attenuates p38 MAP kinase activity in response to ischaemia.
Pantos CI; Malliopoulou VA; Mourouzis IS; Karamanoli EP; Tzeis SM; Carageorgiou HC; Varonos DD; Cokkinos DV
J Endocrinol; 2001 Jul; 170(1):207-15. PubMed ID: 11431153
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning.
Heinen NM; Pütz VE; Görgens JI; Huhn R; Grüber Y; Barthuber C; Preckel B; Pannen BH; Bauer I
Shock; 2011 Jul; 36(1):45-53. PubMed ID: 21478813
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester, but not ischemic preconditioning, activates protein kinase D in the rat heart.
Brooks G; Goss MW; Rozengurt E; Galiñanes M
J Mol Cell Cardiol; 1997 Aug; 29(8):2273-83. PubMed ID: 9281458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
